Mr. Dahai Guo is the Founder & CEO of PuraCap Pharmaceutical LLC., Enspire Group LLC. , Chairman & CEO of Humanwell PuraCap Pharmaceutical (Wuhan) Ltd., etc. He is currently managing six affiliate companies in US & China.
Under Mr. Guo’s leadership, PuraCap Pharmaceutical & its affiliated companies are one of the leaders in specialty pharma & healthcare industry, who is developing, manufacturing and marketing broad range of Branded Rx, Generic Rx and OTC pharmaceutical products in US & the global markets. Currently, PuraCap & affiliates have over 80 different drugs and over 400 products selling in US, China, Canada and other countries. It has four US FDA inspected manufacturing and packaging facilities in US & China.
Through his professional career, Mr. Guo has held senior positions in several multi-billion dollar global companies and also start-up companies in biotech, pharmaceutical and healthcare product industry. He had senior management position in global based public companies like Inverness Medical LLC. (now Aleer), Ansell Healthcare LLC, Roche Group). Mr. Guo has demonstrated strong leadership and broad experience in corporate management, M&A, sales & marketing, product development, global strategic planning and biotechnology research.
Before he came to US in mid 1990’s, Mr. Guo conducted molecular biology research at China’s top research institute, Chinese Academy of Sciences. He has introduced various bio-medical products into China market.
Mr. Guo has MBA from Cornell University and M.S. of Biology from Rutgers University. He also completed distinguish Six-Sigma Black Belt training, awarded by America Society for Quality. Mr. Guo is current Chairman of BioKatalyst Corp, a non-profit organization whose invited-only members are the top management elites of Chinese Americans crossing healthcare industry.